Pharmaceutical Partnerships
PharMerica specializes in the medication needs of older adults and works to stay ahead of potential health issues with emerging treatments. To respond to the needs of all types of long-term care facilities and their residents, we have a long history of developing solutions and partnering with pharmaceutical companies.
PharMerica is the exclusive long-term care pharmacy provider for APOKYN, an FDA-approved treatment for acute, intermittent “off” episodes in patients with advanced Parkinson’s disease (PD). It provides rapid relief and reliable return to an “on” state for residents who experience episodes while waiting for oral medication to work.
As Huntington’s disease progresses and symptoms increase, many residents will require more care, and PharMerica can help. PharMerica is one of only three pharmacies to dispense AUSTEDO™, a medication for treatment of chorea associated with Huntington’s disease.
PharMerica has been selected as a Long-Term Care Pharmacy Provider for KYNMOBI® (apomorphine HCl) sublingual film. KYNMOBI is a prescription medicine used to treat short-term (acute), intermittent OFF episodes in people with Parkinson’s disease (PD).
Want to help patients get started on KYNMOBI? Download and complete the KYNMOBI Prescription & Enrollment Intake Form (for healthcare professional use only).
PharMerica was selected as a Pharmacy Provider for NUPLAZID® (pimavanserin). Please read the full Prescribing Information, including Boxed WARNING, also available at NUPLAZIDhcp.com.
Want to get started with NUPLAZID? Download the NUPLAZID Service Request Form .
Sales Inquiry?
Contact us today to start a new partnership in delivering superior care.
